Navigation Links
Flu Vaccine Can Be Used To Treat Lung Cancer

A group of researchers at Vienna University have said they are trying to develop an existing influenza vaccine so that it will be effective against lung cancer//.

Experiments with mice have already yielded first successes, but much more research was still needed before the new therapy could be used on humans, said a university statement Tuesday.

"In fact it's a paradox," said research scientist Christian Kittel at the Institute of Applied Microbiology.

"Influenza viruses normally cause flu in human beings, and thereby an extremely dangerous illness, which for some patients even ends fatally."

"But now we want to treat an even more dangerous illness, lung cancer, with them," he said.

The researchers explained that the human immune system usually stands no chance against cancer, as it cannot distinguish between healthy and cancerous cells.

But now they had succeeded in altering an existing influenza vaccine so that it acted on the immune system like a sparkplug, giving it a kick-start. Then the system becomes so highly sensitised that it could recognise cancer cells and destroy them, scientists explained.

The existing vaccine was attenuated - a toned-down influenza virus, which could not cause the disease itself but still infected the lungs.

The researchers had developed the virus further so that it now also contained the building plan for production of the immune "messenger" Interleukin-2. This material had already previously been gene-technically manufactured and tested.

"But it was administered to the patients systematically (by infection) and in high dosages. That did in fact have an effect, but also strong side-effects."

This problem would be avoided by using the influenza viruses as conveyances. The virus-infected cells of the lungs would then produce and release the Interleukin-2 just where it was needed.

The substance would activa te the pulmonary immune system to such an extent that it could recognise and fight the cancer.

--DPA
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/25/2017)... ... 2017 , ... FCPX users now have the ability to sharpen a desired ... Color users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical ... tools users can visually see the color range effected with ease all within ...
(Date:2/24/2017)... ... ... Only two months after the official release of The Private Collection – ... Private has initiated a second print-run of its lavish luxury travel coffee table book. ... open, weighs in at more than six kilos, retails at EUR 1,000 per copy ...
(Date:2/24/2017)... ... ... Dr. Ronald E. Hawkins, vice president for academic affairs ... Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of Liberty ... to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), where ...
(Date:2/24/2017)... ... February 24, 2017 , ... With millions of ... critically important that we all are aware of our options and are empowered ... to announce the launch of its newest edition of "Vision and Hearing" in ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... February 24, 2017 Following receiving ... Israel , s AMAR is a major ... 250 M w ound care market in ... BST for inclusion in the National Health Basket ...   E-QURE Corp. (OTCQB: EQUR), a leader ...
(Date:2/24/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the Cowen and Company 37 th ... Place on Tuesday, March 7, 2017 at 11:20 a.m. ... the presentation can be accessed at http://wsw.com/webcast/cowen38/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research and ... and Strategies - 2016" report to their offering. ... The latest research Hemophilia Drugs Price Analysis ... global Hemophilia market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Hemophilia market? ...
Breaking Medicine Technology: